Scott Janis

5.3k total citations · 2 hit papers
25 papers, 1.3k citations indexed

About

Scott Janis is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Rehabilitation. According to data from OpenAlex, Scott Janis has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Rehabilitation. Recurrent topics in Scott Janis's work include Acute Ischemic Stroke Management (18 papers), Cerebrovascular and Carotid Artery Diseases (11 papers) and Stroke Rehabilitation and Recovery (6 papers). Scott Janis is often cited by papers focused on Acute Ischemic Stroke Management (18 papers), Cerebrovascular and Carotid Artery Diseases (11 papers) and Stroke Rehabilitation and Recovery (6 papers). Scott Janis collaborates with scholars based in United States, United Kingdom and Kazakhstan. Scott Janis's co-authors include Joseph P. Broderick, Karen C. Johnston, Yuko Y. Palesch, Christiana E. Hall, Askiel Bruno, William G. Barsan, Catherine Dillon, Valerie Durkalski‐Mauldin, Qi Pauls and Colin P. Derdeyn and has published in prestigious journals such as JAMA, Neurology and Stroke.

In The Last Decade

Scott Janis

24 papers receiving 1.2k citations

Hit Papers

Intensive vs Standard Treatment of Hyperglycemia and Func... 2018 2026 2020 2023 2019 2018 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke
    2019 248 citations Karen C. Johnston, Askiel Bruno et al. profile →
  2. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods
    2018 247 citations Hooman Kamel, W. T. Longstreth et al. International Journal of Stroke profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Janis United States 12 831 464 367 315 264 25 1.3k
Thomas Jeerakathil Canada 19 930 1.1× 448 1.0× 437 1.2× 279 0.9× 238 0.9× 73 1.3k
Gaia Sirimarco Switzerland 21 876 1.1× 585 1.3× 367 1.0× 396 1.3× 164 0.6× 57 1.3k
Huaguang Zheng China 19 865 1.0× 319 0.7× 206 0.6× 300 1.0× 304 1.2× 50 1.2k
K. Vemmos Greece 12 663 0.8× 317 0.7× 305 0.8× 249 0.8× 217 0.8× 18 1.0k
Francesco Palmerini Italy 16 669 0.8× 379 0.8× 392 1.1× 229 0.7× 125 0.5× 22 1.1k
Jae‐Kwan Cha South Korea 24 815 1.0× 326 0.7× 335 0.9× 459 1.5× 290 1.1× 120 1.4k
Apostolοs Safouris Greece 24 975 1.2× 562 1.2× 455 1.2× 247 0.8× 302 1.1× 85 1.4k
Joonsang Yoo South Korea 22 904 1.1× 684 1.5× 377 1.0× 337 1.1× 129 0.5× 88 1.4k
Tomohisa Nezu Japan 17 527 0.6× 431 0.9× 228 0.6× 369 1.2× 118 0.4× 88 1.2k
Wendan Tao China 19 585 0.7× 275 0.6× 308 0.8× 181 0.6× 101 0.4× 57 1.1k

Countries citing papers authored by Scott Janis

Since Specialization
Citations

This map shows the geographic impact of Scott Janis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Janis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Janis more than expected).

Fields of papers citing papers by Scott Janis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Janis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Janis. The network helps show where Scott Janis may publish in the future.

Co-authorship network of co-authors of Scott Janis

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Janis. A scholar is included among the top collaborators of Scott Janis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Janis. Scott Janis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marchina, Sarah, Sharon D. Yeatts, Lydia D. Foster, et al.. (2024). Rationale and Design of the Statin Use in Intracerebral Hemorrhage Patients (SATURN) Trial. Cerebrovascular Diseases. 54(2). 1–1. 4 indexed citations
2.
Gurol, M. Edip, Clinton B. Wright, Scott Janis, et al.. (2023). Stroke Prevention in Atrial Fibrillation: Our Current Failures and Required Research. Stroke. 55(1). 214–225. 8 indexed citations
3.
Naidech, Andrew M., James C. Grotta, Jordan Elm, et al.. (2021). Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial. International Journal of Stroke. 17(7). 806–809. 31 indexed citations
4.
Barreto, Andrew D., Jordan Elm, Colin P. Derdeyn, et al.. (2020). The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methods. International Journal of Stroke. 16(7). 873–880. 26 indexed citations
5.
6.
Turan, Tanya N., Sami Al Kasab, George Cotsonis, et al.. (2019). Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. Cerebrovascular Diseases. 47(1-2). 24–31. 5 indexed citations
7.
Kamel, Hooman, W. T. Longstreth, David Tirschwell, et al.. (2018). The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods. International Journal of Stroke. 14(2). 207–214. 247 indexed citations breakdown →
8.
Turan, Tanya N., George Cotsonis, David Bachman, et al.. (2016). Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis?. Cerebrovascular Diseases. 43(1-2). 31–35. 11 indexed citations
9.
Waters, Michael F., Brian L. Hoh, Michael Lynn, et al.. (2016). Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial. JAMA Neurology. 73(3). 308–308. 47 indexed citations
10.
Mott, Meghan, Scott Janis, & Walter J. Koroshetz. (2016). StrokeNet Takes Off. Stroke. 47(3). e51–2. 9 indexed citations
11.
Chiu, David, Richard Klucznik, Tanya N. Turan, et al.. (2015). Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial. Neurology. 85(24). 2090–2097. 1 indexed citations
12.
Bruno, Askiel, Valerie Durkalski, Christiana E. Hall, et al.. (2014). The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke. PMC. 1 indexed citations
13.
14.
Waters, Michael F., Brian L. Hoh, Michael Lynn, et al.. (2014). Abstract 78: Risk Factors Associated with Failure of Aggressive Medical Therapy in the SAMMPRIS Trial. Stroke. 45(suppl_1). 2 indexed citations
15.
Bruno, Askiel, Valerie Durkalski, Christiana E. Hall, et al.. (2013). The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Protocol: A Randomized, Blinded, Efficacy Trial of Standard vs. Intensive Hyperglycemia Management in Acute Stroke. International Journal of Stroke. 9(2). 246–251. 74 indexed citations
16.
Saver, Jeffrey L., Steven Warach, Scott Janis, et al.. (2012). Standardizing the Structure of Stroke Clinical and Epidemiologic Research Data. Stroke. 43(4). 967–973. 107 indexed citations
17.
Chimowitz, Marc I., Michael Lynn, Tanya N. Turan, et al.. (2011). Design of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. Journal of Stroke and Cerebrovascular Diseases. 20(4). 357–368. 89 indexed citations
18.
Khatri, Pooja, Michael D. Hill, Yuko Y. Palesch, et al.. (2008). Methodology of the Interventional Management of Stroke III Trial. International Journal of Stroke. 3(2). 130–137. 186 indexed citations
19.
Mendell, Jerry R., Cristina Csimma, Craig M. McDonald, et al.. (2006). Challenges in drug development for muscle disease: A stakeholders' meeting. Muscle & Nerve. 35(1). 8–16. 28 indexed citations
20.
Ravina, Bernard, et al.. (2004). Funding evidence: The National Institute of Neurological Disorders and Stroke Clinical Trials Program. PubMed. 1(3). 317–322. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Jeerakathil Breakdown of academic impact, for papers by Gaia Sirimarco Breakdown of academic impact, for papers by Huaguang Zheng Breakdown of academic impact, for papers by K. Vemmos Breakdown of academic impact, for papers by Francesco Palmerini Breakdown of academic impact, for papers by Jae‐Kwan Cha Breakdown of academic impact, for papers by Apostolοs Safouris Breakdown of academic impact, for papers by Joonsang Yoo Breakdown of academic impact, for papers by Tomohisa Nezu Breakdown of academic impact, for papers by Wendan Tao
Rankless by CCL
2026